Changes in cardiac filling pressure (central venous pressure) were measured following carotid occlusion and infusions of catecholamines in awake dogs while cardiac output was held constant. After carotid occlusion in dogs with vagi blocked, central venous pressure increased about 0.8 mm Hg (an estimated decrease in vascular capacity of 2.4 ml/kg). Carotid occlusion before vagal block or following vagal block and /3-adrenergic block with propranolol caused no significant changes in central venous pressure. Phenylephrine (0.1-2.0 ^g/min per kg) caused dose-dependent increases in arterial pressure, but changed central venous pressure (ca. 2.5 mm Hg) only at the highest doses. Epinephrine in doses (0.03-0.51 jig/min per kg) that caused little change in arterial pressure increased central venous pressure up to 5.3 mm Hg (an estimated decrease in vascular capacity of 12.0 ml/kg); this response was attenuated about 50% by propranolol. Isoproterenol (0.01-0.40 /zg/min per kg) decreased arterial pressure and caused changes in central venous pressure similar to those seen with epinephrine. These responses were abolished by propranolol. Vascular compliance, determined from the change in central venous pressure following known changes in vascular blood volume, averaged 3.0 ± 0.6 ml/mm Hg per kg. In the conscious, resting dog, both a-and /3-adrenergic receptors are involved in the reflex control of cardiac filling pressure. The /?-adrenergic responses predominate. (Circ Res 55: 440-453, 1984) 
SUMMARY. Changes in cardiac filling pressure (central venous pressure) were measured following carotid occlusion and infusions of catecholamines in awake dogs while cardiac output was held constant. After carotid occlusion in dogs with vagi blocked, central venous pressure increased about 0.8 mm Hg (an estimated decrease in vascular capacity of 2.4 ml/kg). Carotid occlusion before vagal block or following vagal block and /3-adrenergic block with propranolol caused no significant changes in central venous pressure. Phenylephrine (0.1-2.0 ^g/min per kg) caused dose-dependent increases in arterial pressure, but changed central venous pressure (ca. 2.5 mm Hg) only at the highest doses. Epinephrine in doses (0.03-0.51 jig/min per kg) that caused little change in arterial pressure increased central venous pressure up to 5.3 mm Hg (an estimated decrease in vascular capacity of 12.0 ml/kg); this response was attenuated about 50% by propranolol. Isoproterenol (0.01-0.40 /zg/min per kg) decreased arterial pressure and caused changes in central venous pressure similar to those seen with epinephrine. These responses were abolished by propranolol. Vascular compliance, determined from the change in central venous pressure following known changes in vascular blood volume, averaged 3.0 ± 0.6 ml/mm Hg per kg. In the conscious, resting dog, both a-and /3-adrenergic receptors are involved in the reflex control of cardiac filling pressure. The /?-adrenergic responses predominate. (Circ Res 55: 440-453, 1984) ADEQUATE cardiac filling is essential to maintenance of cardiac output. Cardiac filling pressure is importantly influenced by changes in the properties of the peripheral vascularure and, if all other factors are constant, changes inversely with any alteration in cardiac output. Therefore, studies of the effects of changes in peripheral vascular properties on cardiac filling have required experimental preparations in which cardiac output was held constant. This has been accomplished by a pump in series with or replacing the heart.
In several studies employing pumps, movement of blood into or out of an external reservoir, with central venous pressure and cardiac output held constant, has been used as an index of peripheral vascular influence on cardiac filling. Movement of blood into the reservoir has been defined as a decrease in vascular capacity (Rothe, 1979) . It is also referred to as volume mobilization, since blood moves from the periphery toward the heart. Change in vascular capacity is a measured quantity, usually specified in milliliters per kilogram of body weight. An equally useful index of vascular capacity changes is the change in venous pressure with constant cardiac output and constant blood volume. This measurement has been used in several studies. These two measured values are exchangeable if total systemic compliance is known.
Most investigators have considered alterations in the venous pressure-volume relationship, i.e., changes in the degree of contraction of the smooth muscle of the veins, to be the major cause of changes in vascular capacity (Guyton, 1963; Shoukas and Sagawa, 1973; Drees and Rothe, 1974; Rothe, 1976; Rothe and Drees, 1976; Muller-Ruchholtz et al., 1977a , 1977b Shoukas and Sagawa, 1977; Rothe, 1979; Brunner et al., 1981) . However, some investigators have noted that changes in vascular capacity could also arise from changes in arteriolar and/or venous resistances (Krogh, 1912; Caldini et al., 1974; Mitzner and Goldberg, 1975; Green, 1977; Imai et al., 1978; Rutlen, 1981; Rutlen et al., 1981 ). Such regional changes in resistance may, of themselves, alter vascular capacity and cardiac filling pressure without changes in the venous pressure-volume relationship, even when both cardiac output and blood volume are held constant (Krogh, 1912; Caldini et al., 1974; Mitzner and Goldberg, 1975) .
In most of the acute studies, qualitatively similar results have been reported. Decreases in pressure at the arterial or cardipulmonary baroreceptors (Ross et al., 1961; Pelletier et al., 1971; Shoukas and Sagawa, 1973; Rothe, 1976; Rothe and Drees, 1976; Shoukas and Brunner, 1980; Brunner et al., 1981; Rutlen, 1981) or infusions of a-or /3-adrenergic agents (Rashkind et al., 1953; Rose and Freis, 1957; Ross et al., 1961; Emerson, 1966; Caldini et al., 1974; Drees and Rothe, 1974; Mitzner and Goldberg, 1975; Muller-Ruchholtz et al., 1977a , 1977b Imai et al., 1978; Shoukas and Brunner, 1980) have all caused decreases in vascular capacity (i.e., volume mobilization). At present, it is not possible to evaluate the relative importance of changes in venous tone or changes in arteriolar or venous resistance in the control of vascular capacity in the conscious animal. The surprising finding that vascular capacity decreases with either a-or 0-adrenergic agents needs confirmation and explanation.
Because of the requirement for a constant cardiac output, no experiments have provided quantitative information on the control of vascular capacity in intact, conscious animals. We have developed a procedure to hold cardiac output constant in the dog with atrioventricular (AV) block by changing ventricular rate to compensate for beat-by-beat changes in stroke volume (Wyss et al., 1982) . This procedure converts the heart into a constant-flow pump.
The availability of this procedure for holding cardiac output constant in conscious animals made it possible to accomplish three objectives in the present study: (1) determination of changes in vascular capacity (changes in central venous pressure with cardiac output and blood volume constant) after several doses of catecholamines; (2) determination of changes in vascular capacity from activation of the carotid baroreflex; and (3) determination of the relative roles of a-and /3-adrenergic receptors in the above changes in vascular capacity.
Methods

Surgical Preparation
We trained six mongrel dogs, weighing an average of 22.2 kg, to lie quietly in the laboratory for up to 3 hours. Using aseptic technique, we placed segments of both common carotid arteries in skin tubes (Van Leersum, 1911) . Both vagi were positioned under the skin for block by local anesthetic. A large-bore Silastic catheter was inserted in a jugular vein with the tip in or near the right atrium. Silastic catheters were inserted in a femoral artery and vein with the tips in the thoracic aorta and thoracic vena cava.
The chest was opened through the right 4th intercostal space. The pericardium was incised, and three stainless steel electrodes were sutured to the right ventricle near the apex. The atrioventricular node was blocked using a technique modified from that of Steiner and Kovalik (1968) . An electromagnetic flow transducer (Zepeda Instruments, 18-22 mm ID) was implanted on the ascending aorta. Three electrodes were also sutured to the right atrium. Leads from the electrodes and flow transducer, as well as the jugular and femoral catheters, were brought through the skin between the scapulae. The hearts were paced at 90 beats/min, with sequential AV pacemakers (Intermedics, Inc., Cyberlith IV). At least 2 weeks were allowed for recovery from surgery before experiments were started.
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Experimental Preparation
The dogs were studied while they lay on their left sides with no medication. The ventricle was paced with a stimulator which could be controlled manually or by computer. The arterial and venous catheters were connected to strain gauge transducers for measurement of aortic and central venous pressures. Zero pressure reference was at the midback. An atrial electrogram was used to measure atrial rate.
To change blood volume, heparinized isoncotic dextran (Rheomacrodex, Abbott Labs.), diluted in normal saline, was placed in a sterile vinyl container connected to the large-bore venous catheter. The container was placed in a sealed Plexiglas chamber to which positive or negative pressure could be applied for infusion or hemorrhage, respectively. The weight of this reservoir was measured using a strain gauge transducer with a resolution of 1.0 g.
For the carotid occlusion experiments, pneumatic cuffs were placed around the carotid loops. Both carotid arteries could be occluded simultaneously, without disturbing the animal.
Arterial pressure, central venous pressure, ascending aortic blood flow, ventricular pacing rate, atrial rate, and reservoir weight were continuously recorded on a Beckman oscillograph. The output signal from each recorder channel was converted from analog to digital values and input to a minicomputer (LM 2 ) (Kehl et al., 1975) for processing.
Details of the beat-by-beat computer processing of data have been reported (Wyss et al., 1982) . Briefly, the computer integrated all dynamic variables with respect to time (4-msec sampling interval) so that mean values of arterial pressure, central venous pressure, and ascending aortic blood flow were computed continuously. The computer transferred to magnetic tape the values of all variables, reservoir weight, and elapsed time for each heart beat. Current values of all variables, as well as a running average for the last eight heart beats, were displayed on the computer's video display.
The computer was also used for servo-control of cardiac output (Wyss et al., 1982) . We selected as a target cardiac output the average flow during an initial pacing period at 90 beats/min. After each ventricular stimulus, the computer integrated the flow signal over 400 msec to determine the stroke volume. The interbeat interval required to make cardiac output equal to target cardiac output was then computed, and the stimulator was triggered at the proper time. Pacing rates ranged from 50 to 150 beats/ min.
When arterial pressure was high and filling pressure and/or inotropic state of the heart were low, stroke volume fell markedly, ventricular pacing rate tended to limit at its maximum value, and cardiac output could not be maintained. To overcome this limitation, paired pulse ventricular stimulation was sometimes used. Delivering a second stimulus pulse to the ventricle approximately 200 msec after the initial stimulus causes a marked increase in ventricular contractility (Braunwald et al., 1967) and, therefore, in stroke volume. We noted no effect of paired pulse stimulation on mean central venous pressure (see Discussion).
Experimental Protocols
The protocols are illustrated in Figure 1 . All experiments were done with cardiac output held constant throughout. Since the dogs became restless after 2-3 hours, three separate protocols were used for each dog. At least three replications of each protocol were done in random sequence. Since a minimum of 5 days was allowed between experimental sessions, and since training and surgical preparation required 4-6 weeks, each dog was studied over 12-16 weeks.
In the first protocol, the responses to two or three bilateral carotid occlusions were determined ( Fig. 1 ). Control and experimental responses were taken as the 1minute steady state levels just before and at the end of 3 minutes of carotid occlusion. At least 5 minutes were allowed between each carotid occlusion. In addition, in the first experimental session, total vascular compliance was measured by rapid (0.5-1.0 minute) infusions or hemorrhages ( Fig. 2 ). Because the dogs tended to become restless when venous pressure rose above 12-14 mm Hg, infusions were used which kept venous pressure below this level (typically, 12-13 ml/kg). Also, since decreasing central venous pressure below the control level frequently caused marked decreases in stroke volume, hemorrhage was typically done subsequent to infusion. Similar compliance measurements were made during administration of intermediate (see below) doses of epinephrine. Here, central venous pressure was significantly elevated by the drug, and hemorrhage was done first, followed by reinfusion.
Cardiovascular responses to at least three doses each of epinephrine, norepinephrine, isoproterenol, and phenylephrine were also measured as part of the first experimental protocol. The doses were selected as fractions of the largest dose which caused either extreme hypotension (mean arterial pressure <50 mm Hg), hypertension (mean arterial pressure >170 mm Hg), or arousal and movement by the dog. Since movement caused significant fluctua-tions in arterial and venous pressures, only measurements made during periods without movement were used. All drugs were administered intra-arterially through a T-connector in the arterial catheter using a syringe pump (Harvard Apparatus, model 901). The dose ranges for each drug in Mg/min per kg were: epinephrine, 0.03-0.51; norepinephrine, 0.04-0.5; isoproterenol, 0.01-0.40; and phenylephrine, 0.1-2.0. Each dose was administered for 4-6 minutes, as necessary, to reach a near steady state level of all measured variables for at least 1 minute ( Fig.  3 ). Eight to 15 minutes were allowed between drug administrations for all variables to return to their control levels. Whereas the sequence of drugs in any experiment was varied, the doses of each drug were usually sequential from lowest to highest. Phenylephrine was always administered last, because its effects were longer lasting.
In the second protocol ( Fig. 1) , cardiovascular responses to administration of the three doses each of epinephrine, norepinephrine, and isoproterenol were measured as described above. Beta block was then induced by iv administration of 1.0 mg/kg of propranolol, and the drug infusions were repeated. Typically, only one dose of isoproterenol was given after propranolol because the responses were negligible.
The third protocol consisted of measurement of responses to carotid occlusion after vagal block ( Fig. 1) . A small amount (1-2 ml) of xylocaine (lidocaine, 2%, Astra) was injected subcutaneously along the vagi, followed by 3-5 ml of the longer-acting local anesthetic, bupivicaine HC1 (Marcaine, 0.75%, Breon). Twenty to 30 minutes were allowed for the completion of the block, during which time the dog was prepared for the experiment. An adequate vagal block was assumed when the pupils were dilated, the nictitating membranes were significantly ele- 
100-FIGURE 2. Record from a venous infusion-hemorrhage experiment for measuring vascular compliance. CVP = central venous pressure; MAP -mean arterial pressure; Cl = cardiac index; VR = ventricular pacing rate; RES. WT. = reservoir weight; P a = 1-minute steady state values of CVP; AP E = change in venous pressure by back-extrapolation method. (See text.)
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vated, respiration was slow and deep, and atrial rate was rapid and stable. The carotid arteries were occluded, as described above, before and after administration of propranolol.
Data Processing and Analysis
The data stored on magnetic tape for each heart beat could be averaged over any time period. Ten-second averages were plotted as in Figures 2 and 3. Steady state control and experimental values were computed from the 10-second averaged data.
Vascular compliance (C) was determined by dividing the change in vascular volume (AVOL), following infusion or hemorrhage, by the resulting change in central venous pressure (ACVP): C = AVOL/ACVP. Two different methods were used to determine the change in central venous pressure. In the steady state method, ACVP was computed as the difference between the average venous pressure during the last minute of a volume change and the average venous pressure during the minute just before the volume change. In the back-extrapolation method, the rate of change of central venous pressure determined during the last 2-3 minutes of the 5 to 6 minute volume change was used to extrapolate pressure linearly back in time to the point when the volume change was started (Fig. 2) . The difference between the extrapolated value and the control value was taken as ACVP for the compliance computation.
Replicate determinations of responses to each experi-mental intervention were combined to determine a mean response for each dog. Statistical analyses were done using paired Mests on these mean responses, with each animal serving as its own control. All data are reported as means ± SD unless otherwise stated (differences were considered significant at the P < 0.05 level).
Results
Carotid Occlusion
The effect of bilateral carotid occlusion on central venous pressure was evaluated in six awake dogs with cardiac output held constant under several experimental conditions (Table 1 ; Fig. 4 ). Prior to vagal block, carotid occlusion caused significant vasoconstriction. Total peripheral resistance increased by 27% of control, and mean arterial pressure increased 23 mm Hg. Despite this vasoconstriction, there was no significant change in central venous pressure. Thus, there was no effective decrease in vascular capacity in response to carotid occlusion in the dog with functional vagi.
To potentiate the carotid occlusion response, the interaction from aortic and cardiopulmonary baroreflexes was abolished by bilateral vagal block. Under these conditions, carotid occlusion caused much more vasoconstriction than before vagal block. Total peripheral resistance increased by about 51% and mean arterial pressure by about 44 mm Hg. In contrast to the results before vagal block, central venous pressure increased significantly (by about 0.8 mm Hg). Thus, there was a small but significant decrease in vascular capacity (approximately 2.4 ml/ kg; see below) in response to carotid occlusion in the dogs with vagal block. Carotid occlusion responses were also measured in five of the animals with vagal block following /3block with propranolol. Increases in total peripheral resistance and mean arterial pressure were not significantly different from the responses before propranolol. However, the increases in central venous pressure observed before propranolol were now abolished. Therefore, the decrease in vascular capacity due to carotid occlusion was eliminated by the (8-block. Vagal block alone in the awake dog caused no significant changes in the control levels of total peripheral resistance, mean arterial pressure, or central venous pressure. Similarly, administration of 1.0 mg/kg of propranolol after vagal block caused insignificant changes in these variables.
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Phenylephrine
To evaluate the potential of a-receptor activation to alter vascular capacity, we studied the responses to administration of phenylephrine. The results of 55 observations from six dogs are summarized in Table 2 , and the dose-response relationships for central venous and mean arterial pressures are illustrated in Figure 5 . Although we used a wide range of doses, it was not possible to observe a maximal (limiting) response in most dogs because the higher doses tended to cause the dogs to move, which caused unacceptable changes in arterial and venous pressures.
Phenylephrine caused a dose-dependent vasoconstriction ( Fig. 5) . Except for the very lowest doses, the increases in mean arterial pressure were significant (P < 0.01). Mean arterial pressure increased markedly (about 53 mm Hg) with the largest doses.
In contrast to the dose-dependent vasoconstriction, phenylephrine caused only small increases in central venous pressure. The increase in central venous pressure (ca. 2.5 mm Hg) was significant (P = 0.022) only for the largest doses of phenylephrine. Thus, in the awake dog with cardiac output held constant, it was necessary to activate a-adrenergic receptors at levels causing marked vasoconstriction before a significant decrease in vascular capacity occurred.
Epinephrine
We evaluated the ability of the system to alter vascular capacity further by studying the responses to epinephrine (Table 3; Figs. 3 and 6). As with phenylephrine, the maximal dose of epinephrine was limited by movement of the animals. However, in contrast to phenylephrine, the doses of epinephrine that tended to cause arousal caused little vasoconstriction. Only the highest doses caused a significant increase in mean arterial pressure (ca. 15 mm Hg). Despite the absence of major pressor responses, there were large, significant changes in central ve- nous pressure (P < 0.05) (Fig. 6) , except at the lowest dose. This response tended to reach a plateau with doses of 0.19-0.25 /tg/min per kg. The peak change in central venous pressure was 5.3 ± 0.8 mm Hg, nearly twice as great as that from the largest doses of phenylephrine, even though phenylephrine caused much more vasoconstriction.
Because of the striking differences in the arterial and venous pressure responses to phenylephrine and epinephrine, we studied the response to epinephrine after /8-block with propranolol (Table 3 ; Fig. 6 ). Under these conditions, responses to epinephrine were very similar to those from phenylephrine. All doses of epinephrine now caused significant increases in mean arterial pressure, the largest about 59 mm Hg. However, despite unmasking of the a-adrenergic vasoconstrictor response by the 0-block, no dose of epinephrine caused a significant change in central venous pressure (Fig. 6) . The large pressor response to epinephrine after propranolol prevented us from giving the largest dose administered before propranolol, but these results suggest that the decrease in vascular capacity (increase in central venous pressure) induced by our doses of epinephrine were largely mediated by /?-adrenergic receptors.
Isoproterenol
To evaluate further the effects of jS-agonists on vascular capacity, we measured the responses to Circulation Research/Vol. 55, No. 4, October 1984 several doses of isoproterenol (Table 4 ; Fig. 7) . Analysis of the results was complicated by the extreme sensitivity differences between dogs. A dose that caused a small or moderate response in one dog caused a very large response in another. When maximal doses caused either extreme hypotension or elevation of the intrinsic ventricular rate, combined with marked increases in stroke volume, cardiac output could not be held at the target level. Therefore, we grouped the responses according to their effect. The dose of isoproterenol that caused an increase in central venous pressure of at least 2 mm Hg for any dog was considered the intermediate dose for that animal. Doses one-half and two times the intermediate dose were grouped as low and high doses, respectively, for each dog. The analysis of these groups is shown in Table 4 . Isoproterenolol caused a dose-dependent vasodilation. Mean arterial pressure decreased by as much as 25 mm Hg. Despite the vasodilation, central venous pressure increased by almost 5 mm Hg. Thus, despite its relaxing effect on arteriolar smooth muscle, isoproterenol was nearly twice as effective in increasing central venous pressure as phenylephrine and about as effective as epinephrine. This response was abolished by propranolol and, thus, presumably mediated by ^-adrenergic receptors.
Vascular Compliance
Total vascular compliance was determined to allow comparisons with other experiments and to allow us to estimate the equivalent volume mobilization from changes in venous pressure. We measured the change in central venous pressure in response to known changes in vascular volume (Table  5 ; Fig. 8 ) with cardiac output constant. The average vascular compliance computed from both volume infusions and hemorrhages was 3.0 ± 0.6 ml/mm Hg per kg. This value, determined by the backextrapolation technique (see Methods), may somewhat underestimate the true compliance, since the technique assumes a step change in intravascular pressure, whereas we required about 1 minute to complete the vascular volume changes.
Following volume infusion, 5-6 minutes were allowed to ensure an even distribution of the volume throughout the vasculature and to allow adequate time for slower events, such as stress-relaxation. During this period, central venous pressure gradually decreased (Fig. 2) , presumably due to filtration of fluid from the vasculature. Thus, the compliance computed from the 5-minute steady state change in central venous pressure (see Methods) was significantly greater than the compliance determined by the back-extrapolation method (Table 5 ). This difference was not observed with hemorrhage, subsequent to infusion (Table 5) , since filtered fluid is reabsorbed only slowly when pressures return to control level after a transient increase in capillary pressure (Fig. 2) . We consider the back-extrapolation method to give the best estimate of true vascular compliance. We also measured total vascular compliance during administration of about 0.21 ftg/min per kg of epinephrine (Table 5 ; Fig. 8 ). Under these conditions, vascular compliance was significantly reduced (about 23%).
Experiments in which we measured vascular compliance involved an initial infusion of isoncoric dextran (see Methods). Dextran caused significantly larger changes in central venous pressure than equivalent infusions of blood (Table 5 ; Fig. 8 ). Thus, the vascular compliance measured with dextran was significantly smaller (ca. 23%) than with blood.
Measurement of vascular compliance might be in error if there were a change in the reflex state of the vasculature during the determination. Infusion and hemorrhage did cause significant changes in mean arterial pressure (Table 5 ; Fig. 8 ), but these were not significantly different from the changes in central venous pressure. Since flow was constant, there was no change in total peripheral resistance (Fig. 8) . Therefore, the requirement for a constant state of the vasculature appears to have been met. Also, since the change in pressure in the central veins was not different from the change in the arterial system, it appears that the central venous pressure change reflected the average change in pressure throughout the systemic vasculature.
A similar pattern of arterial pressure and resistance changes was observed during compliance measurements when epinephrine was administered. However, the changes in arterial pressure were more variable and were not statistically significant.
Equivalent Volume Changes
We used the measured changes in central venous pressure and the computed vascular compliance from each dog to estimate the "equivalent volume change* which would have occurred if central venous pressure had been held constant (as in the experiments with a pump and external volume reservoir). The results from carotid occlusion and from the largest doses of each of the pharmacological agents are summarized in Figure 9 . There was no significant change in central venous pressure and, therefore, no volume change with carotid occlusion either before vagal block or with vagal block after propranolol. The estimated volume change by carotid occlusion in the dogs with vagal block prior to /S-block was 2.4 ml/kg. The largest doses of phenylephrine caused a volume change of about 8.4 ml/kg. The largest doses of epinephrine and isoproterenol changed volume by about 12.0 ml/kg. Although there was a clear trend, volume change from epinephrine after /S-block was not significant. The response to isoproterenol was abolished by /3-block.
Although the compliance measured during epi- Table  3 for statistical information.
nephrine infusion was used for estimating the volume shifts from this drug, compliance was not measured during the other experimental interventions. The average control compliance was used for these estimates, so they may be in error by some small Circulation Research/Vol. 55, No. 4, October 1984 amount (<25%) if the compliance was altered by the intervention (Shoukas and Sagawa, 1973; Mitzner and Goldberg, 1975; Green, 1977) .
Cardiac Responses (Fig. 10) Atrial rate was increased significantly by carotid occlusion after, but not before, vagal block (Table  1) , or after combined vagal block and /3-block with propranolol. Effects from epinephrine were variable (Table 3) . Atrial rate was markedly increased by isoproterenol; this response was eliminated by propranolol. The decreases in atrial rate with phenylephrine and with epinephrine after /8-block probably were due to arterial baroreceptor reflexes. Venous infusions of blood caused small increases (4 beats/ min per millimeter of mercury change in central venous pressure) in atrial rate. The response to dextran was nearly twice as large. Responses to hemorrhage were more variable.
Changes in stroke volume (Fig. 10) were evaluated using data without paired-pulse ventricular stimulation (see Methods). Stroke volume did not change with carotid occlusion, except after propranolol in the dogs with vagal block, where, presumably, the increased afterload caused a small decrease in stroke volume. The only change during drug infusions was with the largest dose of isoproterenol. The nearly 50% increase in stroke volume probably was due to the direct and reflex effects of the drug on the heart, along with an increase in filling pressure and a decrease in afterload (Fig. 6 ). Infusion and hemorrhage caused a small increase and decrease, respectively, in stroke volume, although these responses were only about 2% per millimeter of mercury change in filling pressure. Dextran caused a somewhat more marked response, whereas infusion or hemorrhage during administration of epinephrine had no significant effect on stroke volume.
Discussion
This study presents new information concerning the regulation of vascular capacity and cardiac filling Data are means ± SD of the dogs (n = 4 or 5) for control values (prior to isoproterenol) and steady state changes (during isoproterenol) for each dose.
* P < 0.05 or f P < 0.01 by paired f-test.
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pressure in the conscious dog. A common picture is that this regulation occurs via a-adrenergic changes in the venous pressure-volume relationship. Venoconstriction is considered to parallel arteriolar constriction, and to occur with carotid occlusion and with administration of epinephrine. Our data and other recent work (Green, 1977; Muller-Ruchholtz et al., 1977b; Imai et al., 1978; Rutlen et al., 1981) do not support this picture. The decreases we observe in vascular capacity with these two interventions are largely eliminated or greatly decreased with /3-block.
Our findings with administration of catecholamines are surprising in light of the classical picture. The effects of /^-agonists on vascular capacity were larger than the effects of a-agonists over a substantial range of drug doses. We increased drug doses up to the point where increases or decreases in pressure appeared too large, or where animals appeared to be agitated.
Consideration of the Preparation
This study utilizes a novel method for beat-bybeat control of cardiac output in the conscious dog with AV block (Wyss et al., 1982) . It seems worth-449 while to consider whether any of our results might be accounted for by some characteristics of the preparation. Mechanical, humoral, and reflex effects on stroke volume in this preparation were counteracted by opposite changes in heart rate within the same cardiac cycle, which converted the heart into a constant-flow pump. The ventricular rate was changed to maintain cardiac output, and atrial rate changed reflexly, but these rate changes did not have any reflex effects on vascular capacity. We examined the effects of ventricular rate by comparing single and paired pulse ventricular stimulation at the same cardiac output on 18 occasions in five dogs. With paired pulse stimulation, there was a marked increase in stroke volume (about 60%), with a proportionate decrease in ventricular rate, but there were no significant changes in peripheral resistance or in mean central venous pressure. Similarly, the effects of changes in atrial rate were examined by pacing the atria at different rates (up to 180 beats/min), but we observed no changes in resistance or central venous pressure.
In our preparation, we control left heart output for determination of vascular capacity or measurement of compliance. In most of the acute studies, input to the right heart is controlled. We feel that both approaches are valid and give similar results, and that this preparation is well-suited for determining changes in vascular capacity in the awake animal.
Responses to Carotid Occlusion
The responses to carotid occlusion in our animals with vagal block are similar to those observed by others in anesthetized animals. When total peripheral resistance rose by approximately 40%, the vascular capacity changed by about 2.4 ml/kg. This is equivalent to a decrease in vascular capacity of 3% of the blood volume. The decrease in vascular capacity was virtually eliminated by /3-block, and thus appears to be due to the /8-adrenergic action of norepinephrine released from the sympathetic nerve terminals or of epinephrine released from the adrenal medulla. The latter is suggested, since the increase in central venous pressure followed the increase in arterial pressure by 30-40 seconds. Others have noted these differences in response times (Shoukas and Sagawa, 1973; Rothe, 1979) . The reflex responses to carotid occlusion appear comparable to those in other studies of arterial baroreflexes, since the increase in total peripheral resistance which we observed is within the range reported in other studies (Vatner et al., 1970; Shoukas and Sagawa, 1973; Shoukas and Brunner, 1980) .
Responses to Catecholamines
A primary finding in the present study is the strength of P-adrenergic receptors in the control of vascular capacity in awake dogs. Isoproterenol caused marked decreases in vascular capacity. The Compliances (top two rows) are computed from vascular volume change and extrapolated or steady state central venous pressure changes (see Methods). Data are means ± SD of the dogs (n = 5 or 6). Cardiac output was 119.0 ± 34.9 ml/min per kg. * Significant difference between extrapolated and steady state values at P < 0.05 (see Methods). I Significant change from preinfusion or prehemorrhage value at P < 0.05 or $ P < 0.01. largest doses (about 0.24 /tg/min per kg) increased central venous pressure by more than 4 mm Hg, a calculated volume mobilization of about 12 ml/kg. Similar or larger doses of isoproterenol in acute preparations caused net volume mobilizations of only 2.5-5.0 ml/kg (Muller-Ruchholtz et al., 1977b; Imai et al., 1978; Rutlen et al., 1981) . 451 Studies of a-adrenergic control of vascular capacity have yielded varying results. Capacity changes ranged from an increase in capacity (decrease in volume in an external reservoir) of 5 ml/kg with methoxamine (Imai et al., 1978) to a decrease of 2 ml/kg with xylometazolin (Muller-Ruchholtz et al., 1977a) . In our conscious dogs, doses of phenylephrine that caused pressor responses (57% increase in peripheral resistance) similar to those in the acute studies caused small but significant increases in central venous pressure, i.e., decreases in vascular capacity.
FIGURE 8. Panel A: Compliance measurements from blood infusions (I); hemorrhage (H); pooled infusions plus hemorrhage (1 + H); infusions during epinephrine (0.21 tig/min per kg) administration (IE); hemorrhage during epinephrine infusion (HE); pooled infusion plus hemorrhage during epinephrine infusion (1HE); and infusion of dextran (D). Compliances are computed by the back-extrapolation method (see text). Panels B-E show accompanying steady state changes in central venous
Epinephrine has been used for many studies of changes in vascular capacity. Volume mobilization due to this mixed a,fl-agonist ranged from less than 5 ml/kg (Muller-Ruchholtz et al., 1977b) to almost 20 ml/kg (Ross et al., 1961; Emerson, 1966) . Although we used doses one-third to one-tenth of those in the above studies, estimated vascular capacity was reduced by up to 12 ml/kg.
When the jS-adrenergjc component of the response to epinephrine was blocked with propranolol, we observed either elimination or marked attenuation (Table 3 ; Fig. 5 ) of the venous pressure response, while the arterial pressor responses increased.
Infusions of norepinephrine, a mixed a,/8-agonist, have reportedly decreased vascular capacity. Drees and Rothe (1974) culature and reported a potential range of changes in vascular capacity for dogs of about 15 ml/kg. Other studies have reported capacity changes ranging from 2 ml/kg (Muller-Ruchholtz et al., 1977a) to 14 ml/kg from the splanchnic circulation alone . In the former study, there was no attenuation of the vascular capacity response to norepinephrine after propranolol, whereas, in the latter, the response was abolished by /3-block. We studied the vascular responses to administration of norepinephrine in awake dogs (the details are not included in the Results). Norepinephrine (0.04-0.4 ml/min per kg) caused pressor responses similar to those seen with phenylephrine. For the same increase in arterial pressure, changes in central venous pressure (with cardiac output constant) were intermediate between those seen with epinephrine and phenylephrine. The rise in central venous pressure was attenuated, but not abolished, by propranolol. Thus, after propranolol, both epinephrine and norepinephrine caused a pattern of arterial and central venous pressure responses similar to that seen with phenylephrine. When compared to the relatively large /3-adrenergic decrease in vascular capacity, the a-adrenergic responses, although significant, were small. For both isoproterenol and epinephrine, the decreases in vascular capacity for a given dose are substantially greater in the conscious dog than in acute studies.
Mechanisms
Three mechanisms have been proposed to explain (3-adrenergic decreases in vascular capacity. First, some investigators (Ross et al., 1961; Muller-Ruchholtz et al., 1977b) consider volume mobilization as a priori evidence for /3-adrenergic venoconstriction. We believe this to be unlikely, since the majority of experimental evidence indicates that /3-adrenergic stimulation dilates veins (Abboud et al., 1965; Altura, 1978) . Second, others (Green, 1977; Imai et al., 1978; Rutlen et al., 1981) consider that the /3-adrenergic decreases in vascular capacity result from decreases in splanchnic venous outflow resistance. A decrease in venous resistance, with flow constant, causes a decrease in the pressure gradient across that resistance. Thus, upstream (portal venous) pressure decreases and downstream (central venous) pressure increases as blood shifts downstream. (In constant central venous pressure experiments, blood is mobilized into the external reservoir.) It is, of course, possible that venous resistance decreases in several organs. This theory needs further tests. Third, Krogh (1912) and other investigators (Caldini et al., 1974; Mitzner and Goldberg, 1975; Green, 1977; Brunner et al., 1981) have explored the theory that changes in the distribution of blood flow between vascular beds with different mechanical properties give rise to secondary changes in vascular capacity. According to this hypothesis, volume is released passively from an organ when blood flow Circulation Research/Vol. 55, No. 4, October 1984 decreases. The amount of blood released depends on the compliance of the organ and the outflow resistance. If different organs (with different compliance and resistance) change blood flow differentially, there may be a capacity change without any change in venous properties or cardiac output. Experiments designed to test one version of this hypothesis (redistribution of blood flow between splanchnic and other circulations) have given negative results (Mitzner and Goldberg, 1975; Green, 1977; Brunner et al., 1981) , and the hypothesis remains unproven.
Our results call into question the importance of a-adrenergic venoconstriction as a means of decreasing vascular capacity in the conscious dog. Marked a-receptor activation by catecholamines or during carotid occlusion after /3-block was effective in increasing peripheral resistance, but relatively ineffective in increasing central venous pressure. In these cases, either there was little venoconstriction, or venoconstriction was ineffective in decreasing vascular capacity when compared to the effects of /3-adrenergic activation.
